PI Trade Names and Active Ingredients containing Arixtra. 1 Documents available. Need more information on a product? Search the Australian Register of. Mylan manufactures ARIXTRA®* (fondaparinux sodium) Injection, Solution ( Arixtra) in strengths of 25 mg05 mL 5 mgmL5 mg04 mL mgmL75 mg06 mL injection of Arixtra mg in young healthy subjects are provided in Table 1 below: . Arixtra mg once daily following hip fracture surgery, patients were.

Author: Gardazshura Dugal
Country: Singapore
Language: English (Spanish)
Genre: Relationship
Published (Last): 9 December 2011
Pages: 378
PDF File Size: 18.55 Mb
ePub File Size: 20.41 Mb
ISBN: 665-2-61806-503-3
Downloads: 14445
Price: Free* [*Free Regsitration Required]
Uploader: Gusho

PDR Search

Per the manufacturer of ticlopidine, if a patient is switched from an anticoagulant or a thrombolytic agent to ticlopidine, the former drug should be discontinued prior to the administration of ticlopidine. It would be prudent for clinicians to monitor the INR and patient’s clinical status closely if trazodone is added to or removed from the regimen of a patient stabilized on anticoagulant therapy.

Moderate Due to the risk of bleeding with natural antineoplastics, patients should receive other agents that may increase the risk of bleeding, such as anticoagulants. Fondaparinux should be injected into the left or right anterolateral or posterolateral abdominal wall. Arkxtra Caution should be used when administering tipranavir to patients receiving adixtra. Adults weight 50 kg or more.

Moderate Caution is advised when administering miltefosine with anticoagulants, as use of these drugs together may increase risk for bleeding. Occurrence of major bleeds in clinical trials for fondaparinux prophylaxis in hip fracture, hip replacement, or knee replacement surgery was 1.

Major During and after therapy, avoid the concomitant use of Yttrium Y srixtra tiuxetan with drugs that interfere with coagulation such as anticoagulants; the risk of bleeding may be increased. The manufacturer suggests that if platelet counts fall belowmm3, fondaparinux should be discontinued. Moderate Telavancin has no effect on coagulation or platelet aggregation; however, caution is advised when administering telavancin concurrently with anticoagulants as telavancin may interfere with laboratory tests used in monitoring these medications.


Thus, patients receiving anticoagulation due to a history of these conditions are not candidates for prasterone treatment.

Arixtra (fondaparinux sodium) dose, indications, adverse effects, interactions from

Moderate Cautious use of injectable collagenase by patients taking anticoagulants is advised. Other clinical data exist that describe spontaneous subdural hematomas associated with chronic ginkgo biloba ingestion. International standards of heparin or LMWH are not calibrators to measure anti-factor Xa activity of fondaparinux.

The extent and duration of the hypocoagulable state induced by hemin has not been established. Theoretically, the risk of bleeding may be increased, but some studies that combined these agents did not produce clinically significant bleeding events.

The patient discontinued green tea and one week later his INR was 2. Clinicians should consider the risk versus benefit of neuraxial intervention in patients anticoagulated or to be anticoagulated.

There was no statistically significant difference in INRs between the placebo or treatment period within each group. However, in clinical trials with abciximab, aspirin and heparin were administered concomitantly.

Prasterone is also contraindicated in patients with active arterial thromboembolic disease for example, stroke and myocardial infarctionor a history of these conditions. The injection site should be rotated with each injection.

Recipient’s Email Separate multiple email address with a comma Please enter valid email address Recipient’s email is required.

Fondaparinux is administered by subcutaneous injection.

Kava Kava, Piper methysticum: If switching from another anticoagulant to apixaban, discontinue arixtta other anticoagulant and start apixaban at the usual time of the next dose of the other anticoagulant. Severe Coadministration of defibrotide with antithrombotic agents like anticoagulants is contraindicated. Periodic complete blood counts, serum creatinine levels and stool occult blood tests are recommended.


Aneurysm, diabetic retinopathy, diverticulitis, hemophilia, hepatic disease, hypertension, idiopathic thrombocytopenic purpura ITPinflammatory bowel disease, menstruation, peptic ulcer disease, vaginal bleeding.

Agents which may lead to an increased incidence of bleeding in patients with thrombocytopenia include anticoagulants. There was also no difference in INRs found between groups.

TGA eBS – Product and Consumer Medicine Information

Major Guarana has been shown to possess minor antiplatelet activity and, therefore, concurrent use of guarana and anticoagulants or platelet inhibitors should be avoided. Ginkgo, Ginkgo biloba is reported to inhibit platelet aggregation and several case reports describe bleeding complications adixtra Ginkgo biloba, with or without concomitant drug therapy.

Moderate Because fulvestrant is given intramuscularly, it should not be used or given with caution in patients receiving anticoagulants. A reduction in death or reinfarction rate significantly favored fondaparinux treatment at 9 days 8. Major Discontinue rivaroxaban before starting fondaparinux due to the increased bleeding risk, unless these agents are essential. Moderate Drug interactions with fish oil, omega-3 fatty acids Afixtra Supplements or fish oil, omega-3 fatty acids FDA-approved are unclear at this time.

Patients who choose to consume methylsulfonylmethane, MSM while receiving warfarin should be observed for increased bleeding. Pentosan is a weak anticoagulant. Moderate Additive bleeding may occur if anticoagulants are given in combination with ginger, zingiber officinale. Moderate Concomitant use of eptifibatide and other agents arixtrw may affect hemostasis, such as anticoagulants, may be associated with an increased risk of bleeding.